Buscar
Congreso SOLACI
HomeACC.15.Day 2

Day 2

Ver Categoría
Day 2

SCOT-HEART: Coronary angiography by tomography in patients with suspected coronary artery disease

The aim of this study was to evaluate Coronary angiography by multislice CT compared with standard therapy...
solaci -
Ver más
Day 2

OSLER: Evolocumab reduces cardiovascular events compared with standard statin therapy

The aim of this study was to evaluate the safety and efficacy of long-term Evolocumab, an inhibitor...
solaci -
Ver más
Day 2

ODYSSEY LONG TERM: alirocumab reduces LDL in patients with maximum tolerated doses of statins

The aim of this study was to evaluate treatment with alirocumab a monoclonal antibody against PCSK9 receptor,...
solaci -
Ver más
Day 2

NOTION: TAVR in low-risk patients

The aim of this study was to compare the results of transcatheter aortic valve replacement (TAVR) versus...
solaci -
Ver más
Day 2

EMBRACE STEMI: Bendavia a new drug to prevent mitochondrial dysfunction in AMI.

The purpose of this phase 2 study was to test the safety and efficacy of new drug...
solaci -
Ver más
Day 2

CSPPT: folic acid for primary prevention of stroke

The aim of this study was to evaluate the effectiveness of supplementation with folic acid in primary...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Evolution of Small Balloon-Expandable Valves

Dr. Carlos Fava - 0
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

solaci - 0
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

Noticias Institucionales

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad